Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Squamous Non Small Cell Lung Cancer × necitumumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 10 Neoplasms 2 Lung Neoplasms 2 Squamous Non-small Cell Lung Cancer 1 Squamous Non Small Cell Lung Cancer 1 Solid Tumors 1 Solid Tumor, Adult 1 Non-small Cell Lung Cancer Metastatic 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma 1 Breast Neoplasms 1

Interventions

Paclitaxel 2 necitumumab 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01769391 2019-09-20

A Study of Necitumumab and Chemotherapy in Participants With Stage IV Squamous Non-Small Cell Lung Cancer

Eli Lilly and Company

Phase 2 Completed

167 enrolled 17 charts

Squamous Non Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡